Side-by-side financials for FBRX and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FBRX | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #49 |
| Revenue (latest FY) | $36.00K | - |
| Net income (latest FY) | -$69.38M | - |
| Net margin | -192708.3% | - |
| SEC filings | 595 | 1,004 |
Full pages: Forte Biosciences, Inc. and AstraZeneca PLC, or browse the full rankings.